| Literature DB >> 26959403 |
Nataly Lino Izeli1, Aurélia Juliana Dos Santos1, Júlio César Crescêncio1, Ana Clara Campagnolo Real Gonçalves1, Valéria Papa1, Fabiana Marques1, Antônio Pazin-Filho2, Lourenço Gallo-Júnior1, André Schmidt1.
Abstract
BACKGROUND: Numerous studies show the benefits of exercise training after myocardial infarction (MI). Nevertheless, the effects on function and remodeling are still controversial.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26959403 PMCID: PMC4845704 DOI: 10.5935/abc.20160031
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Baseline characteristics of the trained and control groups (TG and CG, respectively)
| Age (years) | 54.1 ± 7.0 | 50.3 ± 9.7 | 0.87 |
| Time from MI (days) | 145.0 ± 104.7 | 117.5 ± 91.1 | 0.99 |
| Killip class, I/II/III (n) | 10/8/0 | 4/3/1 | 0.31 |
| Weight (kg) | 80.0 ± 14.8 | 90.5 ± 12.4 | 0.08 |
| Body mass index (kg/m2) | 28.1 ± 3.9 | 30.2 ± 3.1 | 0.34 |
| EF (%) | 45.1 ± 11.8 | 44.9 ± 11.0 | 0.80 |
| Culprit lesion artery (%) | 0.60 | ||
| Left anterior descending | 66.6 | 50.0 | |
| Left circumflex coronary | 16.7 | 37.5 | |
| Right coronary artery | 16.7 | 12.5 | |
| Revascularization procedures (n) | 0.44 | ||
| PTCA | 14 | 5 | |
| CABG surgery | 1 | 0 | |
| Hypertension | 61.1 | 75.0 | 0.67 |
| Dyslipidemia | 66.7 | 37.5 | 0.22 |
| Diabetes mellitus | 22.2 | 37.5 | 0.64 |
| Family history | 44.4 | 37.5 | 1.00 |
| Current smokers | 0 | 50.0 | 0.0047 |
| Sedentary | 50.0 | 100 | 0.0098 |
| Overweight | 72.2 | 100 | 0.10 |
| Antithrombotic agent | 100 | 100 | 1.00 |
| β-blocker | 100 | 100 | 1.00 |
| ACEI or ARB | 88.8 | 87.5 | 1.00 |
| Statin | 100 | 100 | 1.00 |
| Diuretics | 22.2 | 25.0 | 1.00 |
MI: myocardial infarction; EF: ejection fraction; PTCA: percutaneous transluminal coronary angioplasty; CABG: coronary artery bypass grafting; ACEI: angiotensin-converting-enzyme inhibitors; ARB: angiotensin-receptor blockers.
Lipid profile and fasting glucose values (mean ± SD) in the trained and control groups (TG and CG, respectively) at baseline and follow-up
| Total cholesterol (mg/dL) | 157.4 ± 43.8 | 147.9 ± 47.9 | 170.1 ± 44.8 | 178.1 ± 44.5 |
| Triglycerides (mg/dL) | 168.5 ± 76.7 | 140.1 ± 66.4 | 226.0 ± 112.9 | 319.1 ± 194.1 |
| HDL-c (mg/dL) | 37.4 ± 7.1 | 39.3 ± 10.0 | 39.8 ± 4.1 | 40.4 ± 5.7 |
| LDL-c (mg/dL) | 86.3 ± 36.8 | 81.0 ± 34.8 | 73.8 ± 12.2 | 73.2 ± 27.3 |
| Fasting glucose (mg/dL) | 106.0 ± 26.4 | 94.5 ± 14.8 | 114.8 ± 42.5 | 122.4 ± 38.8 |
p = 0.011.
Data from exercise tests (mean ± SD) from the trained and control groups (TG and CG, respectively) at baseline and follow-up
| Peak HR (bpm) | 132.0 ± 20.2 | 140.2 ± 20.1 | 127.0 ± 21.0 | 125.4 ± 26.5 |
| Peak systolic blood pressure (mmHg) | 178.3 ± 24.6 | 181.1 ± 22.1 | 183.8 ± 16.0 | 193.8 ± 23.4 |
| Peak HR-pressure product (bpm.mmHg) | 23598.6 ± 5093.5 | 25540.8 ± 5640.0 | 23612.5 ± 6353.0 | 24312.5 ± 5997.9 |
| Metabolic equivalent (MET) | 10.1 ± 2.3 | 14.0 ± 2.8 | 8.7 ± 2.7 | 8.6 ± 2.5 |
| Peak oxygen uptake (mL/kg/min) | 35.4 ± 8.1 | 49.1 ± 9.6 | 30.3 ± 9.5 | 30.2 ± 8.9 |
| Speed (mph) | 3.07 ± 0.5 | 3.8 ± 0.7 | 2.9 ± 0.3 | 2.9 ± 0.5 |
| Ramp inclination (%) | 15.9 ± 3.6 | 19.1 ± 3.0 | 13.5 ± 4.9 | 13.0 ± 3.5 |
HR: heart rate.
p < 0.0001;
p = 0.0026.
Cardiac magnetic resonance (CMR) measurements (mean ± SD) from the trained and control groups (TG and CG, respectively) at baseline and follow-up
| EDV (mL) | 110.7 ± 43.5 | 116.8 ± 38.2 | 126.3 ± 39.4 | 134.3 ± 42.2 |
| Indexed EDV (mL/m2) | 38.5 ± 14.1 | 40.6 ± 12.3 | 42.2 ± 12.5 | 44.4 ± 11.9 |
| EF (%) | 45.1 ± 11.8 | 46.8 ± 10.0 | 44.9 ± 11.0 | 42.6 ± 11.6 |
| LVmass (g) | 128.7 ± 38.9 | 117.2 ± 27.2 | 159.6 ± 29.3 | 167.8 ± 49.7 |
| Indexed LVmass (g/m2) | 44.9 ± 12.5 | 40.9 ± 8.6 | 53.6 ± 10.4 | 55.9 ± 14.0 |
| LVmass/EDV ratio (g/mL) | 1.29 ± 0.36 | 1.36 ± 0.48 | 1.05 ± 0.22 | 1.30 ± 0.37 |
EDV: end-diastolic volume; EF: ejection fraction; LV: left ventricular.
p = 0.0032;
p = 0.0225 between baseline values of the two groups;
p = 0.0429 between baseline values of the two groups;
p = 0.015.